SCHEMBL7302128

SCHEMBL7302128

CC(C#N)c1ccc(C(=O)O)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.48
TP53 P04637 1/20 0.48
KMT2A Q03164 1/20 0.46
ALDH1A1 P00352 3/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
SRD5A2 P31213 2/20 0.43
ANPEP P15144 1/20 0.43
RXRA P19793 3/20 0.42
RXRB P28702 3/20 0.42
NR1H4 Q96RI1 1/20 0.42
RXRG P48443 1/20 0.42
CA1 P00915 3/20 0.41
CA2 P00918 3/20 0.41
CA12 O43570 1/20 0.41
CA3 P07451 1/20 0.41
TYR P14679 1/20 0.41
DRD1 P21728 1/20 0.41
CA4 P22748 1/20 0.41
CA6 P23280 1/20 0.41
CA5A P35218 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9695884 0.98 TSHR (0.46) TSHRTP53KMT2AALDH1A1SMN1; SMN2
SCHEMBL30949430 0.82 PARP10 (0.47) TSHRKMT2AALDH1A1SMN1; SMN2CA1
SCHEMBL9695879 0.82 ALDH1A1 (0.40) KMT2AALDH1A1SMN1; SMN2HPGDLMNA
SCHEMBL6132150 0.80 TSHR (0.48) TSHRTP53KMT2AALDH1A1SMN1; SMN2
SCHEMBL6565095 0.80 ESR1 (0.43) TSHRKMT2AALDH1A1
SCHEMBL8734246 0.79 CA1 (0.50) TSHRTP53KMT2AALDH1A1CA1
SCHEMBL11852788 0.79 PGR (0.44) ALDH1A1SMN1; SMN2NR1H4HPGDLMNA
SCHEMBL31386185 0.79 CA1 (0.50) TSHRTP53KMT2AALDH1A1CA1
SCHEMBL28184575 0.79 KDM4E (0.51) KMT2AALDH1A1SMN1; SMN2RXRARXRB
SCHEMBL687298 0.78 ANPEP (0.50) KMT2AALDH1A1SMN1; SMN2ANPEPRXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118005638-A Pyrazolo [3,4-d ] pyrimidine structure-containing compound, and preparation method and application thereof 西安新通药物研究股份有限公司 2024-05-10 CN disclosed
CN-117659022-A Ureido substituted pyridine compound, pharmaceutical composition containing ureido substituted pyridine compound and medical application of ureido substituted pyridine compound 苏州阿尔脉生物科技有限公司 2024-03-08 CN disclosed
EP-0874826-A1 NAPHTHALENE QUINOLINES HAVING LEUKOTRIENE-ANTAGONISTIC ACTION LABORATORIOS MENARINI S.A. (ES) 1998-11-04 EP disclosed
WO-1997024331-A1 NAPHTHALENE QUINOLINES HAVING LEUKOTRIENE-ANTAGONISTIC ACTION LABORATORIOS MENARINI S.A. (ES) 1997-07-10 WO disclosed
EP-0358118-B1 Phenylamides - process for their preparation as well as a drug containing those compounds BOEHRINGER MANNHEIM GMBH (DE) 1994-03-16 EP disclosed
US-5135949-A Anticoagulants BOEHRINGER MANNHEIM GMBH (DE) 1992-08-04 US disclosed